Commercially available assays for multiplex detection of alpha human papillomaviruses
- 1 October 2010
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Review of Anti-infective Therapy
- Vol. 8 (10), 1139-1162
- https://doi.org/10.1586/eri.10.104
Abstract
Five main groups of commercial assays for the multiplex detection of alpha human papillomaviruses (HPVs) are currently available. DNA-based screening assays, which test for the presence of 13-14 HPVs without determination of HPV type, have been the standard for HPV detection in the last decade. Assays that combine testing for 14 HPVs and HPV-16 and HPV-18 genotyping are a potential future standard for HPV detection. The clinical value of HPV genotyping assays has still not been finally determined. Recently, one of the mRNA-based assays showed equal clinical sensitivity but higher clinical specificity for CIN2+/CIN3+ in comparison with the validated DNA-based assay. In situ hybridization assays are too laborious and have insufficient clinical sensitivity to be used in routine screening. Automation, price reduction and improvement of clinical specificity are the main goals for the future development of HPV assays.Keywords
This publication has 152 references indexed in Scilit:
- How to evaluate emerging technologies in cervical cancer screening?International Journal of Cancer, 2009
- Comparison of the PapilloCheck® DNA micro-array Human Papillomavirus detection assay with Hybrid Capture II and PCR-enzyme immunoassay using the GP5/6+ primer setJournal of Clinical Virology, 2009
- Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinantsInternational Journal of Cancer, 2009
- Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirusJournal of Virological Methods, 2009
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and olderInternational Journal of Cancer, 2008
- Comparison of the performance of different HPV genotyping methods for detecting genital HPV typesJournal of Medical Virology, 2008
- 2006 consensus guidelines for the management of women with abnormal cervical cancer screening testsAmerican Journal of Obstetrics and Gynecology, 2007
- Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis updateInternational Journal of Cancer, 2007
- Overview of the European and North American studies on HPV testing in primary cervical cancer screeningInternational Journal of Cancer, 2006
- Against which human papillomavirus types shall we vaccinate and screen? the international perspectiveInternational Journal of Cancer, 2004